Literature DB >> 6617717

Reduction of phenytoin clearance caused by cimetidine.

G M Frigo, S Lecchini, M Caravaggi, G Gatti, M Tonini, L D'Angelo, E Perucca, A Crema.   

Abstract

The effect of cimetidine on the disposition kinetics of phenytoin was investigated in 7 healthy volunteers. Each subject received a single intravenous dose of phenytoin on two occasions, in the control state, and during concurrent treatment with cimetidine 1 200 mg/day for 6 days. A slight but statistically significant decrease both in the rate of elimination and total body clearance of phenytoin was observed during the administration of cimetidine. The effect is probably due to inhibition of metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617717     DOI: 10.1007/bf00544030

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.

Authors:  W C Randolph; V L Osborne; S S Walkenstein; A P Intoccia
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

3.  Cimetidine interaction with phenytoin.

Authors:  D J Hetzel; F Bochner; J F Hallpike; D J Shearman; C S Hann
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

Review 4.  Drug interactions with cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Decreased clearance of phenytoin with cimetidine.

Authors:  G J Algozzine; R B Stewart; P K Springer
Journal:  Ann Intern Med       Date:  1981-08       Impact factor: 25.391

Review 6.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 7.  Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

8.  Effect of cimetidine on phenytoin serum levels.

Authors:  R B Salem; B D Breland; S K Mishra; J E Jordan
Journal:  Epilepsia       Date:  1983-06       Impact factor: 5.864

9.  Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.

Authors:  P J Neuvonen; R A Tokola; M Kaste
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.

Authors:  E Perucca; S Hebdige; G M Frigo; G Gatti; S Lecchini; A Crema
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

  10 in total
  9 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 2.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 3.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 5.  Differential kinetics of phenytoin in elderly patients.

Authors:  K A Bachmann; R J Belloto
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 6.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

7.  A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.

Authors:  N C Sambol; R A Upton; A N Chremos; E T Lin; R L Williams
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 8.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

Review 9.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.